CoronaryAtlas logo
CoronaryAtlas
Mitochondrial DNA (mtDNA)
Pathway / Plaque inflammation

Mitochondrial DNA (mtDNA)

other

mtDNA released from injured cells activates pattern-recognition receptors to trigger innate immune activation and plaque inflammation in atherosclerosis.

Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleReleased from damaged cells; acts as a DAMP (danger-associated molecular pattern) to trigger innate inflammation and atherosclerosis progression.
Also acts inMyocardial injury
Druggability
Not assessed (no mapped human gene target).

Type I vs non-Type I discrimination

ScoresShared / rises in both
R — rupture / Type-I
67
C — non-Type-I
52
A — assay feasibility
45
E — evidence strength
28
T1DI (composite)
7
Specificity differential (R−C)+14.3
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
2hypovolemia / dehydrationn/a
2tachyarrhythmiamag 1
2hypoxemia / respiratory failuremag 2
2hypertensive emergencyn/a
2high-demand / peri-operative stressmag 1
3sudden cardiac deathmag 1
4aPCI-related periproceduralmag 2
4bstent thrombosisn/a
4cin-stent restenosisn/a
5CABG-relatedmag 2
Coverage: 7/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 17 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST)
Method / principle
Method depends on analyte chemistry
Reagent / substrate
Analyte-specific
Platform
Variable
Turnaround · availability
Research · Research

Literature evidence(3)